Eucrates Biomedical Acquisition Corp Watch

from 8-K 6 pages Promissory Note

from 8-K 6 pages Promissory Note

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 18 pages Indemnity Agreement

from 8-K 10 pages Unit Subscription Agreement

from 8-K 6 pages This Letter Is Being Delivered to You in Accordance With the Underwriting Agreement (The “Underwriting Agreement”) Entered Into by and Between Eucrates Biomedical Acquisition Corp., a British Virgin Islands Company (The “Company”), and Stifel, Nicolaus & Company, Incorporated and H.C. Wainwright & Co., LLC as Representatives (The “Representatives”) of the Several Underwriters Named in Schedule a Thereto (The “Underwriters”), Relating to an Underwritten Initial Public Offering (The “Ipo”) of the Company’s Units (The “Units”), Each Comprised of One Ordinary Share, No Par Value, of the Company (The “Ordinary Shares”), and One-Third of One Warrant (The “Warrant”), Which Each Whole Warrant Entitles the Holder Thereof to Purchase One Ordinary Share. Certain Capitalized Terms Used Herein Are Defined in Paragraph 15 Hereof

from 8-K 19 pages Registration Rights Agreement

from 8-K 15 pages Investment Management Trust Agreement

from S-1/A 18 pages Indemnity Agreement

from S-1/A 19 pages Registration Rights Agreement

from S-1/A 10 pages Unit Subscription Agreement

from S-1/A 7 pages 1. Purchase of Shares. for the Aggregate Sum of $25,000 (The “Purchase Price”), Which the Company Acknowledges Receiving in Cash, the Company Hereby Sells and Issues to the Subscriber, and the Subscriber Hereby Purchases From the Company the Shares, for a Purchase Price of Approximately $0.009 Per Share, Subject to Forfeiture by the Subscriber, on the Terms and Subject to the Conditions Set Forth in This Agreement. Concurrently With the Subscriber’s Execution of This Agreement, the Company Is Delivering to the Subscriber Certificate(s) Registered in the Subscriber’s Name Representing the Shares, Receipt of Which the Subscriber Hereby Acknowledges. 2. Representations, Warranties and Agreements. 2.1 Subscriber’s Representations, Warranties and Agreements. to Induce the Company to Issue the Shares to the Subscriber, the Subscriber Hereby Represents and Warrants to the Company and Agrees With the Company as Follows: 2.1.1. No Government Recommendation or Approval. the Subscriber Understands That No United States Federal or State Agency or Similar Agency of Any Other Country Has Passed Upon or Made Any Recommendation or Endorsement of the Offering of the Shares